Clinical Trial

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

Study acronym: AVOCADO-T2D
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-07-14; most recent amendment 2025-07-28.
Status change: Not Yet Recruiting → Recruiting 2023-10-24
Trial Details
NCT Number NCT05958368
Lead Sponsor Pennington Biomedical Research Center
Collaborators: Prachi Singh, Frank L. Greenway, Robbie A. Beyl
Conditions Diabetes Mellitus, Type 2, Insulin, Fructosamine, C-Reactive Protein, Glucose, Overweight and Obesity
Enrollment 48 participants
Start Date 2023-10-10
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-31